Table 2. Univariate and multivariate analyses of overall survival in HCC patients.
Variable | Univariate analyses | Multivariate analyses | ||||
---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |
CK2α | 2.708 | 1.512–4.850 | 0.001a | 1.971 | 1.006–3.642 | 0.03a |
Age | 1.148 | 0.647–2.036 | 0.637 | |||
Sex | 0.767 | 0.275–2.137 | 0.612 | |||
Tumor size | 1.790 | 0.929–3.450 | 0.082 | |||
Histological grade | 1.520 | 1.084–2.132 | 0.015a | 0.849 | ||
Liver cirrhosis | 1.557 | 0.774–3.132 | 0.215 | |||
HBV | 0.922 | 0.413–2.059 | 0.843 | |||
AFP | 1.733 | 0.975–3.078 | 0.061 | |||
Tumor capsule | 0.576 | 0.322–1.030 | 0.063 | |||
Vascular | 1.837 | 0.930–3.626 | 0.080 | |||
TNM stage | 2.535 | 1.411–4.554 | 0.002a | 2.008 | 1.094–3.686 | 0.024a |
Distant metastasis | 2.666 | 1.463–4.858 | 0.001a | 2.120 | 1.144–3.926 | 0.017a |
HR, hazard ratio; CI, confidence interval; AFP, alfa fetoprotein; TNM, tumor, node, metastasis.
P < 0.05.